Natco rolls out Baricitinib ahead of approval for patent waiver

Even as it has filed for a compulsory licence for Covid-19 drug Baricitinib in India, Natco Pharma has already begun rolling out its generic version of the rheumatoid arthritis drug under the Barinat brand.



May 07, 2021 at 04:30AM